CD4+ T cell calibration of antigen-presenting cells optimizes antiviral CD8+ T cell immunity

Elise Gressier(The University of Melbourne), Jonas Schulte-Schrepping(University of Bonn), L. A. Petrov(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Sophia Brumhard(Charité - Universitätsmedizin Berlin), Paula Stubbemann(Charité - Universitätsmedizin Berlin), Anna Hiller(Charité - Universitätsmedizin Berlin), Benedikt Obermayer(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Jasper Spitzer(University of Bonn), Tomislav Kostevc(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Paul G. Whitney(The University of Melbourne), Annabell Bachem(The University of Melbourne), Alexandru Odainic(University of Bonn), Carolien E. van de Sandt(The University of Melbourne), Thi H. O. Nguyen(The University of Melbourne), Thomas M. Ashhurst(The University of Sydney), Kayla R. Wilson(The University of Melbourne), Clare V. Oates(The University of Melbourne), Linden J. Gearing(Hudson Institute of Medical Research), Tina Meischel(The University of Melbourne), Katharina Hochheiser(The University of Melbourne), Marie Greyer(The University of Melbourne), Michele V. Clarke(The University of Melbourne), Maike Kreutzenbeck(University of Bonn), Sarah S. Gabriel(The University of Melbourne), Wolfgang Kastenmüller(University of Würzburg), Christian Kurts(University of Bonn), Sarah L. Londrigan(The University of Melbourne), Axel Kallies(The University of Melbourne), Katherine Kedzierska(The University of Melbourne), Paul J. Hertzog(Hudson Institute of Medical Research), Eicke Latz(University of Bonn), Yu-Chen Enya Chen(The University of Queensland), Kristen J. Radford(The University of Queensland), Michaël Chopin(Australian Regenerative Medicine Institute), Jan Schröder(The University of Melbourne), Florian Kurth(Charité - Universitätsmedizin Berlin), Thomas Gebhardt(The University of Melbourne), Leif Erik Sander(Charité - Universitätsmedizin Berlin), Birgit Sawitzki(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Joachim L. Schultze(University of Bonn), Susanne V. Schmidt(University of Bonn), Sammy Bedoui(University of Bonn)
Nature Immunology
May 15, 2023
Cited by 40Open Access
Full Text

Abstract

Antiviral CD8+ T cell immunity depends on the integration of various contextual cues, but how antigen-presenting cells (APCs) consolidate these signals for decoding by T cells remains unclear. Here, we describe gradual interferon-α/interferon-β (IFNα/β)-induced transcriptional adaptations that endow APCs with the capacity to rapidly activate the transcriptional regulators p65, IRF1 and FOS after CD4+ T cell-mediated CD40 stimulation. While these responses operate through broadly used signaling components, they induce a unique set of co-stimulatory molecules and soluble mediators that cannot be elicited by IFNα/β or CD40 alone. These responses are critical for the acquisition of antiviral CD8+ T cell effector function, and their activity in APCs from individuals infected with severe acute respiratory syndrome coronavirus 2 correlates with milder disease. These observations uncover a sequential integration process whereby APCs rely on CD4+ T cells to select the innate circuits that guide antiviral CD8+ T cell responses. Bedoui and colleagues describe a sequential process of integration of innate and CD40-delivered signals in APCs, which optimizes their capacity to drive antiviral CD8+ T cell responses.


Related Papers

No related papers found

Powered by citation graph analysis